Promoter hypermethylation: a new therapeutic target emerges in urothelial cancer
- PMID: 15753457
- DOI: 10.1200/JCO.2005.11.923
Promoter hypermethylation: a new therapeutic target emerges in urothelial cancer
Comment on
-
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.J Clin Oncol. 2005 May 1;23(13):2903-10. doi: 10.1200/JCO.2005.03.163. Epub 2005 Mar 7. J Clin Oncol. 2005. PMID: 15753461
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources